Literature DB >> 28828312

Another feather in the crown of medical safety and ethics in India.

Krishnan Vengadaragava Chary1.   

Abstract

Entities:  

Year:  2017        PMID: 28828312      PMCID: PMC5543768          DOI: 10.4103/2229-3485.210448

Source DB:  PubMed          Journal:  Perspect Clin Res        ISSN: 2229-3485


× No keyword cloud information.
Sir,

RURAL PHARMACOVIGILANCE

According to National Survey, nearly 80 million of Indians reside in rural areas, consuming medicines for various diseases and data from them are absolutely essential to make Pharmacovigilance Programme of India (PvPI) penultimate. Indian Council of Medical Research (ICMR) extended this service. ICMR-based rural pharmacovigilance comprises allocating funds to ADR monitoring centers (AMCs) and employing a qualified pharmacist to collect drug safety data of the community in which they are posted and submit it to the nearest AMCs.[1]

PATIENT INITIATED MEDICINE SAFETY REPORTING

The hallmark of PvPI, India is the introduction of medicine drug side effects reporting. Undoubtedly, this is successful in western and European nations. The complexity involved in implementing this in our country including people of diverse culture and language, low literacy has been overcome by introducing simple drug side effect reporting form, called 'blue form' against conventional 'red form' used by health-care workers. Direct consumer reporting is further facilitated by availability of forms in eleven Indian vernacular languages including Hindi, Tamil, Telugu, Gujarati, Marathi, etc.[2] This increases autonomy of patients to report adverse effects from over the counter drugs, out of participation in clinical trials and due to conventional medicines. Patient/consumer can report through toll-free number 1800 180 3024 or forms can be E-mailed to pvpi.compat@gmail.com. Introduction of various measures to increase pharmacovigilance seems to be effective and optimistic. Every medical professionals, paramedical staffs, and patients should be under their responsibility in contributing the drug safety measures failing which the results may not be appreciable.[3]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  1 in total

1.  System of adverse drug reactions reporting: What, where, how, and whom to report?

Authors:  Vivekanandan Kalaiselvan; Pranay Kumar; Prabhakar Mishra; Gyanendra Nath Singh
Journal:  Indian J Crit Care Med       Date:  2015-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.